CD8A and hepatocellular carcinoma: Specifically, the close interaction between activated neutrophils/classical M1 macrophages and DCs via ligand–receptor pairs allowed increased tumor antigen presentation to CD8+ cytotoxic T cells, resulting in antitumor immunity against HCC.